ANTI-STATHMIN BIFUNCTIONAL SMALL HAIRPIN RNA: PRECLINICAL DEVE

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$199,045.00
Award Year:
2010
Program:
SBIR
Phase:
Phase I
Contract:
N43CO201000108
Agency Tracking Number:
N43CO201000108
Solicitation Year:
2010
Solicitation Topic Code:
NCI
Solicitation Number:
PHS2010-1
Small Business Information
GRADALIS, INC.
1717 MAIN STREET, 60TH FLOOR, DALLAS, TX, 75201-
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
610368925
Principal Investigator:
Alex Tong
Business Contact:
DAVE SHANAHAN
(214) 220-4304
Research Institution:
n/a
Abstract
The three basic requirements for an effective RNA interference-based therapy are 1) identification of key genetic defect[s] that provide pivotal survival advantage(s) to the overall cancer cell population

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government